Replies to post #49003 on $.0001-$.0011 News, DDs & Charts Only!!!

[mick]

Coronvirus Update: A Surge In New Tests
The cumulative total of confirmed coronavirus cases worldwide rose by more than 112,000, a 1.9% increase, to more than 5.9 million. The number of deaths rose 1.3% to 362,555, according to Worldometer data. The share of those cases occurring in European Economic Area countries continued to decrease, falling to 23.4% on Friday. EEA countries had reported just over 45% of the total worldwide deaths from the virus, according to data from the European Center for Disease Prevention and Control.

The U.S. confirmed 22,697 new cases and reported another 1,230 deaths. That put the U.S. share of total coronavirus cases worldwide below 30%, to 29.8%. The U.S. share of total deaths from the disease held steady at 28.5%.

Brazil's rate of infection accelerated sharply, surpassing the U.S. with more than 24,000 new patients reported in the 24 hours to Friday morning. Russia's rate of increase held about steady, reporting 8,572 new cases.

Among U.S. states, new cases in New York, New Jersey and California continued to hover around the 2,000 level. Illinois, Texas, Maryland and Virginia all continued to report around 1,000 new cases per day.

Testing in the U.S. surged, with states reporting a total of 453,560 tests performed on Thursday. That is the highest daily number to date, and lifted the 10-day average for tests to 384,251 — the first increase in that average in two days, but still below Monday's high above 392,000.

Coronavirus Stocks: Moderna, BioNTech, Pfizer Rise
Among stocks associated with the coronavirus pandemic, Moderna (MRNA) popped nearly 4% and BioNTech (BNTX) gained almost 2% in early trade.

Moderna shares bounced more than 6% on Thursday, after the company clinched an extended manufacturing deal for a potential coronavirus vaccine now in clinical testing. The move put shares in a buy range on a rebound from the stock's 10-week moving average.

Germany-based BioNTech is partnered with blue chip drugmaker Pfizer (PFE), developing a Covid-19 vaccine candidate that is now in clinical testing in the U.S. BioNTech is looking to snap a five-day decline, and retake support at its 10-week moving average. Pfizer shares were up 0.6%, one of the top premarket advances on the Dow Jones today.